New Delhi

It said in a statement that the city has been allocated a total of 51,540 vials of Amphotericin-B for the treatment of the disease, out of which 42,960 vials "have been received and distributed to hospitals, and 8,080 vials are awaited".

"(The) Government of India has now discontinued the allocation and directed all State Governments to procure Amphotericin B Injection from the manufacturers directly as per their requirement," the statement said.

The Delhi government has also procured 26,700 vials of Liposomal Amphotericin B and 25,000 vials of Amphotericin B Lipid Complex, it said.

"Private hospitals are also now procuring directly from manufacturers," the statement added.